Barcellini (Policlinico Milano): “Benefits with ravulizumab for patients with paroxysmal nocturnal hemoglobinuria”
"For patients with paroxysmal nocturnal hemoglobinuria (Epn), until recently the therapy was only supportive: transfusions, folic acid, iron supplementation, up ...